drugset / Trial / NCT05156528
Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the efficacy, immunogenicity and safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in infants and children aged from 6 months to 5 years.
Timeline
- Start
- 2021-12-11
- Primary completion
- 2024-01-11
- Completion
- 2024-01-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine | Vaccine | 0.5 ml | Intramuscular |